Skip to content

Public FDA record

Z-0826-2010: Encore Medical Foundation Knee Revision Baseplate, Part Number 321-01-106, Size 6, Left

Recall record Z-0826-2010 for Encore Medical, Lp. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0826-2010
Company in FDA record
Encore Medical, Lp
FDA classification date
Feb 24, 2010
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Partial lot of product was not manufactured to specification. Central locking screw was missing threads. There is a potential for dissociation because the screw is not able to be used as a secondary fixation method.

Source facts

Action
Firm notified consignees by letter on 12/11/2009. The letter informs physicians that patients with implanted devices should counseled about the issue and should report any changes to their treating physician.
Initiated
2009-12-11
Root cause
Process control
Terminated
2010-09-24
Distribution
TX, FL, GA, CA, AZ, Japan
Recall number
Z-0826-2010
Recall status
Terminated
CDRH record ID
87810
FDA classified
2010-02-24
Recall event number
54197

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗